798 results on '"Sullman, Mark"'
Search Results
202. Additional file 3 of Global, regional, and national burden of Guillain���Barr�� syndrome and its underlying causes from 1990 to 2019
- Author
-
Bragazzi, Nicola Luigi, Kolahi, Ali-Asghar, Nejadghaderi, Seyed Aria, Lochner, Piergiorgio, Brigo, Francesco, Naldi, Andrea, Lanteri, Paola, Garbarino, Sergio, Sullman, Mark J. M., Dai, Haijiang, Wu, Jianhong, Kong, Jude Dzevela, Jahrami, Haitham, Sohrabi, Mohammad-Reza, and Safiri, Saeid
- Abstract
Additional file 3: Table S3. Years lived with disability (YLDs) due to Guillain���Barre syndrome in 1990 and 2019 and the percentage change in the age-standardised rates (ASRs) per 100,000, by location (Generated from data available from http://ghdx.healthdata.org/gbd-results-tool ).
- Published
- 2021
- Full Text
- View/download PDF
203. Additional file 7 of Global, regional, and national burden of Guillain���Barr�� syndrome and its underlying causes from 1990 to 2019
- Author
-
Bragazzi, Nicola Luigi, Kolahi, Ali-Asghar, Nejadghaderi, Seyed Aria, Lochner, Piergiorgio, Brigo, Francesco, Naldi, Andrea, Lanteri, Paola, Garbarino, Sergio, Sullman, Mark J. M., Dai, Haijiang, Wu, Jianhong, Kong, Jude Dzevela, Jahrami, Haitham, Sohrabi, Mohammad-Reza, and Safiri, Saeid
- Abstract
Additional file 7: Figure S4. The percentage change in the age-standardised years lived with disability (YLDs) rates of Guillain���Barre syndrome from 1990 to 2019 for the 21 Global Burden of Disease regions, by sex. The error bars represent 95% uncertainty intervals for the percentage change in age-standardised YLD rates per 100,000 population between 1990 and 2019. (Generated from data available from http://ghdx.healthdata.org/gbd-results-tool ).
- Published
- 2021
- Full Text
- View/download PDF
204. Additional file 5 of Burden of anemia and its underlying causes in 204 countries and territories, 1990���2019: results from the Global Burden of Disease Study 2019
- Author
-
Safiri, Saeid, Kolahi, Ali-Asghar, Noori, Maryam, Nejadghaderi, Seyed Aria, Karamzad, Nahid, Bragazzi, Nicola Luigi, Sullman, Mark J. M., Abdollahi, Morteza, Collins, Gary S., Kaufman, Jay S., and Grieger, Jessica A.
- Abstract
Additional file 5: Figure S2. The age-standardized years lived with disability (YLDs) rates of anemia in 2019 for the 21 Global Burden of Disease regions, by sex. (Generated from data available from http://ghdx.healthdata.org/gbd-results-tool ).
- Published
- 2021
- Full Text
- View/download PDF
205. Additional file 8 of Global, regional, and national burden of Guillain���Barr�� syndrome and its underlying causes from 1990 to 2019
- Author
-
Bragazzi, Nicola Luigi, Kolahi, Ali-Asghar, Nejadghaderi, Seyed Aria, Lochner, Piergiorgio, Brigo, Francesco, Naldi, Andrea, Lanteri, Paola, Garbarino, Sergio, Sullman, Mark J. M., Dai, Haijiang, Wu, Jianhong, Kong, Jude Dzevela, Jahrami, Haitham, Sohrabi, Mohammad-Reza, and Safiri, Saeid
- Abstract
Additional file 8: Figure S5. Global number of years lived with disability (YLDs) cases and years lived with disability (YLDs) of Guillain���Barre syndrome per 100,000 population, by age and sex in 2019. The error bars represent 95% uncertainty intervals for total number of YLDs. Dotted and dashed lines indicate 95% uncertainty intervals for YLD (per 100,000). (Generated from data available from http://ghdx.healthdata.org/gbd-results-tool ).
- Published
- 2021
- Full Text
- View/download PDF
206. Cardiac complications following mRNA COVID‐19 vaccines: A systematic review of case reports and case series.
- Author
-
Fazlollahi, Asra, Zahmatyar, Mahdi, Noori, Maryam, Nejadghaderi, Seyed Aria, Sullman, Mark J. M., Shekarriz‐Foumani, Reza, Kolahi, Ali‐Asghar, Singh, Kuljit, and Safiri, Saeid
- Abstract
There have been several local and systemic adverse events associated with mRNA COVID‐19 vaccines. Pericarditis, myocarditis and myocardial infarction are examples of cardiac complications related to these vaccines. In this article, we conducted a systematic review of case reports and case series to identify the clinical profile, investigations, and management of reported cardiac complications post‐mRNA COVID‐19 vaccines. We systematically searched PubMed, Scopus, Web of Science, and Google Scholar, as well as the medRxiv preprint server, with terms including: 'SARS‐CoV‐2', 'COVID‐19', 'messenger RNA vaccine*', 'mRNA‐1273 vaccine', 'BNT162 vaccine', 'myocarditis', 'pericarditis', 'stroke' and 'Myocardial Ischemia' up to 25 September 2021. Studies were excluded if they were not case reports or case series, or reported cases from non‐mRNA vaccines. Case reports and case series were included that investigated the potential cardiac complications associated with mRNA COVID‐19 vaccines. The JBI checklist was used to assess quality and data synthesis was conducted using a qualitative methodology called narrative synthesis. Sixty‐nine studies, including 43 case reports and 26 case series, were included. Myocarditis/myopericarditis and pericarditis were the most common adverse events among the 243 reported cardiac complications, post mRNA COVID‐19 vaccination. Males with a median age of 21 years had the highest frequency of myocarditis. Almost three quarters (74.4%) of cases with myocarditis had received the BNT162b2 vaccine and 87.7% had received the second dose of the vaccine. Chest pain (96.1%) and fever (38.2%) were the most common presentations. CK‐MB, troponin, and NT‐proBNP were elevated in 100%, 99.5% and 78.3% of subjects, respectively. ST‐segment abnormality was the most common electrocardiogram feature. Cardiac magnetic resonance imaging, which is the gold‐standard approach for diagnosing myocarditis, was abnormal in all patients diagnosed with myocarditis. Non‐steroidal anti‐inflammatory drugs were the most prescribed medication for the management of myocarditis. Apart from inflammatory conditions, some rare cases of Takotsubo cardiomyopathy, myocardial infarction, myocardial infarction with non‐obstructive coronary arteries, and isolated tachycardia were also reported following immunisation with mRNA COVID‐19 vaccines. We acknowledge that only reviewing case reports and case series studies is one potential limitation of our study. We found that myocarditis was the most commonly reported adverse cardiac event associated with mRNA COVID‐19 vaccines, which presented as chest pain with a rise in cardiac biomarkers. Further large‐scale observational studies are recommended. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
207. Attitudes Toward Four Levels of Self-Driving Technology Among Elderly Drivers
- Author
-
Lajunen, Timo, primary and Sullman, Mark J. M., additional
- Published
- 2021
- Full Text
- View/download PDF
208. Facebook Intrusion as a Mediator Between Positive Capital and General Distress: A Cross-Cultural Study
- Author
-
Przepiórka, Aneta, primary, Błachnio, Agata, additional, Sullman, Mark, additional, Gorbaniuk, Oleg, additional, Siu, Nicolson Yat-Fan, additional, Hill, Tetiana, additional, Gras, Maria-Eugenia, additional, Kagialis, Antonios, additional, Lisun, Yanina, additional, Díaz-Peñaloza, Maité, additional, Manrique-Millones, Denisse, additional, Nikiforou, Militsa, additional, Evtina, Galina S., additional, Taylor, Joanne E., additional, Tekes, Burcu, additional, Šeibokaite, Laura, additional, Wundersitz, Lisa, additional, Calvo, Fran, additional, and Font-Mayolas, Sílvia, additional
- Published
- 2021
- Full Text
- View/download PDF
209. Epidemiology, prognosis and management of potassium disorders in Covid‐19
- Author
-
Noori, Maryam, primary, Nejadghaderi, Seyed A., additional, Sullman, Mark J. M., additional, Carson‐Chahhoud, Kristin, additional, Kolahi, Ali‐Asghar, additional, and Safiri, Saeid, additional
- Published
- 2021
- Full Text
- View/download PDF
210. The Tabriz Older People Survey (TOPS-2019): A community-based cross-sectional study
- Author
-
Araj-Khodaei, Mostafa, primary, Sanaie, Sarvin, additional, Nejadghaderi, Seyed Aria, additional, Sullman, Mark J M, additional, Sis, Sirous Samei, additional, Yousefi, Zahra, additional, Safiri, Saeid, additional, and Azizi-Zeinalhajlou, Akbar, additional
- Published
- 2021
- Full Text
- View/download PDF
211. Letter to the editor regarding: “Cannabis and its constituents for cancer: history, biogenesis, chemistry, and pharmacological activities”
- Author
-
Taghizadieh, Ali, primary, Hanaee, Jalal, additional, Ghazi-Sha’rbaf, Javad, additional, Sullman, Mark J. M, additional, and Mohammadinasab, Reza, additional
- Published
- 2021
- Full Text
- View/download PDF
212. Psychosocial factors associated with the self-reported frequency of cell phone use while driving in Iran
- Author
-
Kalantari, Amir Hossein, primary, Monavar Yazdi, Seyedeh, additional, Hill, Tetiana, additional, Mohammadzadeh Moghaddam, Abolfazl, additional, Ayati, Esmaeel, additional, and Sullman, Mark J. M., additional
- Published
- 2021
- Full Text
- View/download PDF
213. Coronavirus disease 2019 (Covid‐19) vaccination recommendations in special populations and patients with existing comorbidities.
- Author
-
Mohseni Afshar, Zeinab, Babazadeh, Arefeh, Janbakhsh, Alireza, Mansouri, Feizollah, Sio, Terence T., Sullman, Mark J. M., Carson‐Chahhoud, Kristin, Hosseinzadeh, Rezvan, Barary, Mohammad, and Ebrahimpour, Soheil
- Abstract
Summary: Vaccination against severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is a crucial step in ending the current worldwide pandemic. However, several particularly vulnerable groups in the population were not included in sufficient numbers in coronavirus disease 2019 (Covid‐19) vaccine trials. Therefore, as science advances, the advice for vaccinating these special populations against Covid‐19 will continue to evolve. This focused review provides the latest recommendations and considerations for these special populations (i.e., patients with rheumatologic and autoimmune disorders, cancer, transplant recipients, chronic liver diseases, end‐stage renal disease, neurologic disorders, psychiatric disorders, diabetes mellitus, obesity, cardiovascular diseases, chronic obstructive pulmonary disease, human immunodeficiency virus, current smokers, pregnant and breastfeeding women, the elderly, children, and patients with allergic reactions) using the currently available research evidence. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
214. Global, regional, and national burden of migraine in 204 countries and territories, 1990 to 2019
- Author
-
Safiri, Saeid, primary, Pourfathi, Hojjat, additional, Eagan, Arielle, additional, Mansournia, Mohammad Ali, additional, Khodayari, Mohammad Taghi, additional, Sullman, Mark J.M., additional, Kaufman, Jay, additional, Collins, Gary, additional, Dai, Haijiang, additional, Bragazzi, Nicola Luigi, additional, and Kolahi, Ali-Asghar, additional
- Published
- 2021
- Full Text
- View/download PDF
215. Mobile phone applications use while driving in Ukraine: Self-reported frequencies and psychosocial factors underpinning this risky behaviour
- Author
-
Hill, Tetiana, primary, Stephens, Amanda N., additional, and Sullman, Mark J. M., additional
- Published
- 2021
- Full Text
- View/download PDF
216. Serum Hepcidin, the Hepcidin/Ferritin Ratio and the Risk of Type 2 Diabetes: A Systematic Review and Meta-Analysis
- Author
-
Karamzad, Nahid, primary, Eftekhari, Aziz, additional, Ashrafi-Asgarabad, Ahad, additional, Sullman, Mark J.M., additional, Sahebkar, Amirhossein, additional, and Safiri, Saeid, additional
- Published
- 2021
- Full Text
- View/download PDF
217. Why people make friends: Evidence from 12 nations.
- Author
-
Apostolou, Menelaos, Sullman, Mark J.M., Ayers, Jessica D., Błachnio, Agata, Choubisa, Rajneesh, Gadelrab, Hesham F., Hill, Tetiana, Kamble, Shanmukh, Lisun, Yanina, Manrique-Millones, Denisse, Millones-Rivalles, Rosa, Ohtsubo, Yohsuke, Przepiórka, Aneta, Tekeş, Burcu, Cruz, Germano Vera, Wang, Yan, Watanabe, Yukino, and Ghorbani, Arya
- Subjects
- *
CAREER development , *RELATIONSHIP status , *MACHIAVELLIANISM (Psychology) , *PSYCHOPATHY , *COUNTRIES - Abstract
People make friends for a variety of reasons. The current study aimed to explore these reasons and the role of the Dark Triad in predicting them, using self-report questionnaires in a sample drawn from 12 countries. We found that the most important reasons for making friends were having people around with desirable traits such as compatibility, who could provide support and be relied upon in times of need, and with whom one could frequently socialize. Less important reasons included achieving self-serving goals such as career advancement and securing an intimate partner. We found small effects of age, sex, and relationship status. Furthermore, higher scores in Machiavellianism and Narcissism were associated with a greater emphasis on all reasons, particularly on achieving self-serving goals. Conversely, higher Psychopathy scores were associated with a lower importance placed on all reasons except mating, where they were associated with higher importance. • Examined the reasons why people make friends in a sample drawn from 12 countries • Found cross-cultural consistency in the reasons for making friends • Found cross-cultural variations in the reasons for making friends • Found significant effects of Dark Triad on the reasons for making friends [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
218. The Connor-Davidson resilience scale (CD-RISC) amongst young spanish adults = La escala de resiliencia de Connor-Davidson en adultos españoles jóvenes
- Author
-
Gras Pérez, María Eugenia, Font-Mayolas, Sílvia, Baltasar Bagué, Alícia, Patiño Masó, Josefina, Sullman, Mark J.M., and Planes Pedra, Montserrat
- Subjects
Quality of life ,Resiliència (Tret de la personalitat) ,Qualitat de vida ,Resilience (Personality trait) - Abstract
The interest in resilience has grown over the last few decades due to its relationships with health, well-being, and quality of life. Several instruments have been developed to measure resilience, with one of the most common being the Connor-Davidson Resilience Scale (CD-RISC). This scale has been validated in many cultures with divergent results. This paper investigates the factor structure of the CD-RISC. Participants were 3,214 students (62.1% female, mean age = 21.01, SD = 2.86) who were randomly divided into two equal subsamples (n = 1,607). One subsample was used to explore which models best fit the data and these models were fitted using the other subsample. Confirmatory factor analysis did not support the original 5-factor CD-RISC. The analyses supported unidimensional scale structures for both the 22-item and 10-item versions of the scale. The shorter instrument reduces the time needed to answer the questionnaire, allows it to be combined with other instruments, and does not require large sample sizes
- Published
- 2020
219. Predictors of intentions to use cigarettes and electronic-cigarettes among high school students
- Author
-
Patiño-Masó,Josefina, Font-Mayolas,SÃlvia, Salamó,Anna, Arboix,Montserrat, Sullman,Mark J. M., and Gras,Maria-Eugenia
- Subjects
Journal of Multidisciplinary Healthcare ,Electronic cigarettes ,Adolescents -- Consum de tabac ,Cigarretes electròniques ,Teenagers -- Tobacco use - Abstract
Josefina Patiño-Masó,1 Sílvia Font-Mayolas,2 Anna Salamó,2 Montserrat Arboix,3 Mark JM Sullman,4 Maria-Eugenia Gras21Department of Nursing, Institut de Recerca Sobre Qualitat de Vida, Universitat de Girona, Girona, Catalunya, Spain; 2Department of Psychology, Institut de Recerca Sobre Qualitat de Vida, Universitat de Girona, Girona, Catalunya, Spain; 3Department of Health, Escola Municipal del Treball, Granollers, Catalunya, Spain; 4Department of Social Sciences, School of Humanities and Social Sciences, University of Nicosia, Nicosia, CyprusPurpose: Tobacco is the second most commonly used drug by Spanish high school students and e-cigarette use has increased over the last three years among this population. Students who reported smoking tobacco and/or e-cigarette use often have friends and family that also consume these substances. The aims of the present study were to: determine the prevalence of tobacco and electronic cigarette consumption among young adolescents, the age of initiation and the intention to consume both of these substances in the future; study the relationships between their current tobacco and e-cigarette consumption status, intentions to consume these substances in the future and the consumption of these substances by family members living in their home and friend’s consumption status; investigate the relationship between their current tobacco and e-cigarette consumption status, friends’ consumption status and their intention to consume each substance in the future; analyse the relationship between current consumption status, intentions to consume in the future and perceived risk; identify the main predictors of intentions to use these substances in the future.Methods: A cross-sectional survey was conducted in 2017. The sample consisted of 468 school students in the first cycle of secondary education in Catalonia, Spain. The participants who were aged between 11 and 15years old, with 49.4% being female.Results: A stepwise binary logistic regression showed that the best predictors of the intention to smoke tobacco in the future were: having tried tobacco, being a current consumer, having a family member smoking at home and having a low perceived risk of smoking. The best predictors of the intention to use electronic cigarettes in the future were: having tried tobacco, being a current consumer and having friends who smoke or use electronic cigarettes.Conclusion: Smoking prevention programs must consider the social network surrounding teenagers, particularly close friends and family. Intervention strategies for delaying the onset of tobacco or e-cigarette consumption are greatly needed.Keywords: adolescence, tobacco use, electronic cigarette, parental smoking, risk perceptions, adolescent smoking
- Published
- 2020
220. Motivation for change and the pros and cons of smoking in a Spanish population
- Author
-
Font-Mayolas, SiLvia, Planes, Montserrat, Gras, Ma EugeNia, and Sullman, Mark J.M.
- Subjects
Smoking cessation programs ,Health ,Sociology and social work - Abstract
To link to full-text access for this article, visit this link: http://dx.doi.org/10.1016/j.addbeh.2006.03.029 Byline: Silvia Font-Mayolas (a), Montserrat Planes (a), Ma Eugenia Gras (a), Mark J.M. Sullman (b) Keywords: Stages of change; Smoking cessation; Pros and cons of smoking Abstract: Decisional balance and the stage of change have been used to understand the motivation for giving up the habit of smoking. The objective of this study was to find out whether the associations between the pros and the cons of smoking, taking into account the magnitude and delay parameters, and stages of change, can be demonstrated in a sample of Spanish smokers and ex-smokers using a cross-sectional design. The results are compared with the patterns of pros and cons of smoking found in samples of American, Swiss and Dutch smokers. The data confirms that amongst Spanish smokers it is also in the stages of contemplation and preparation that the crossover in the valuation of the pros and cons of smoking takes place: the cons hold more weight than the pros. On the other hand, unexpectedly, the pros of smoking are more highly valued in the stages of action and maintenance than in the rest of the stages. Author Affiliation: (a) Quality of Life Research Institute, University of Girona, C/ Emili Grahit, 77, 17071 Girona, Catalonia, Spain (b) Department of Human Resource Management, Massey University, New Zealand
- Published
- 2007
221. Driving anger in Spain
- Author
-
Sullman, Mark J.M., Gras, M. Eugenia, Cunill, Monica, Planes, Monserrat, and Font-Mayolas, Silvia
- Published
- 2007
- Full Text
- View/download PDF
222. Predictors of seat belt use amongst Spanish drivers
- Author
-
Eugenia Gras, M., Cunill, Monica, Sullman, Mark J.M., Planes, Monserrat, and Font-Mayolas, Silvia
- Published
- 2007
- Full Text
- View/download PDF
223. Mobile phone use while driving in a sample of Spanish university workers
- Author
-
Gras, M. Eugenia, Cunill, Monica, Sullman, Mark J.M., Planes, Montserrat, Aymerich, Maria, and Font-Mayolas, Silvia
- Published
- 2007
- Full Text
- View/download PDF
224. Why people make friends: The nature of friendship
- Author
-
Apostolou, Menelaos, primary, Keramari, Despoina, additional, Kagialis, Antonios, additional, and Sullman, Mark, additional
- Published
- 2020
- Full Text
- View/download PDF
225. Helmet Use for the Prevention of Brain Injuries in Motorcycle Accidents
- Author
-
Fuentes-Pumarola, Concepci, primary, Bertran, Carme, additional, Eugnia, M., additional, Font-Mayolas, Slvia, additional, Ballester, David, additional, M. Sullman, Mark J., additional, and Juviny, Dolors, additional
- Published
- 2012
- Full Text
- View/download PDF
226. The burden of stroke and its attributable risk factors in the Middle East and North Africa region, 1990–2019.
- Author
-
Jaberinezhad, Mehran, Farhoudi, Mehdi, Nejadghaderi, Seyed Aria, Alizadeh, Mahasti, Sullman, Mark J. M., Carson-Chahhoud, Kristin, Collins, Gary S., and Safiri, Saeid
- Subjects
DISEASE risk factors ,COVID-19 ,GLOBAL burden of disease ,HYPERTENSION ,AGE groups ,BODY mass index ,SYSTOLIC blood pressure - Abstract
Stroke is one of the leading causes of mortality and morbidity across the globe. Providing comprehensive data on the burden of stroke in the Middle East and North Africa (MENA) could be useful for health policy makers in the region. Therefore, this article reported the burden of stroke and its attributable risk factors between 1990 and 2019 by age, sex, type of stroke, and socio-demographic index. Data on the point prevalence, death, and disability-adjusted life-years (DALYs), due to stroke, were retrieved from the Global Burden of Disease study 2019 for the 21 countries located in the MENA region from 1990 to 2019. The counts and age-standardised rates (per 100,000) were presented, along with their corresponding 95% uncertainty intervals (UIs). In 2019, the regional age-standardised point prevalence and death rates of stroke were 1537.5 (95% UI: 1421.9–1659.9) and 87.7 (78.2–97.6) per 100,000, which represent a 0.5% (− 2.3 to 1.1) and 27.8% (− 35.4 to − 16) decrease since 1990, respectively. Moreover, the regional age-standardised DALY rate in 2019 was 1826.2 (1635.3–2026.2) per 100,000, a 32.0% (− 39.1 to − 23.3) decrease since 1990. In 2019, Afghanistan [3498.2 (2508.8–4500.4)] and Lebanon [752.9 (593.3–935.9)] had the highest and lowest age-standardised DALY rates, respectively. Regionally, the total number of stroke cases were highest in the 60–64 age group and was more prevalent in women in all age groups. In addition, there was a general negative association between SDI and the burden of stoke from 1990 to 2019. Also, in 2019, high systolic blood pressure [53.5%], high body mass index [39.4%] and ambient particulate air pollution [27.1%] made the three largest contributions to the burden of stroke in the MENA region. The stroke burden has decreased in the MENA region over the last three decades, although there are large inter-country differences. Preventive programs should be implemented which focus on metabolic risk factors, especially among older females in low SDI countries. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
227. Challenges posed by COVID-19 in cancer patients: A narrative review.
- Author
-
Afshar, Zeinab Mohseni, Hosseinzadeh, Rezvan, Barary, Mohammad, Ebrahimpour, Soheil, Alijanpour, Amirmasoud, Sayad, Babak, Hosseinzadeh, Dariush, Miri, Seyed Rouhollah, Sio, Terence T., Sullman, Mark J. M., Carson-Chahhoud, Kristin, and Babazadeh, Arefeh
- Subjects
SARS-CoV-2 ,COVID-19 ,CORONAVIRUS diseases ,CANCER patients - Abstract
A novel coronavirus, or severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was identified as the causative agent of coronavirus disease 2019 (COVID-19). In early 2020, the World Health Organization declared COVID-19 the sixth public health emergency of international concern. The COVID-19 pandemic has substantially affected many groups within the general population, but particularly those with extant clinical conditions, such as having or being treated for cancer. Cancer patients are at a higher risk of developing severe COVID-19 since the malignancy and chemotherapy may negatively affect the immune system, and their immunocompromised condition also increases the risk of infection. Substantial international efforts are currently underway to develop specific methods for diagnosing and treating COVID-19. However, cancer patients' risk profiles, management, and outcomes are not well understood. Thus, the main objective of this review is to discuss the relevant evidence to understand the prognosis of COVID-19 infections in cancer patients more clearly, as well as helping to improve the clinical management of these patients. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
228. Global, regional, and national burden of migraine in 204 countries and territories, 1990 to 2019.
- Author
-
Safiri, Saeid, Pourfathi, Hojjat, Eagan, Arielle, Mansournia, Mohammad Ali, Khodayari, Mohammad Taghi, Sullman, Mark J.M., Kaufman, Jay, Collins, Gary, Dai, Haijiang, Bragazzi, Nicola Luigi, and Kolahi, Ali-Asghar
- Published
- 2022
- Full Text
- View/download PDF
229. Prevalence, Deaths, and Disability-Adjusted Life-Years Due to Asthma and Its Attributable Risk Factors in 204 Countries and Territories, 1990-2019.
- Author
-
Safiri, Saeid, Carson-Chahhoud, Kristin, Karamzad, Nahid, Sullman, Mark J.M., Nejadghaderi, Seyed Aria, Taghizadieh, Ali, Bell, Arielle Wilder, Kolahi, Ali-Asghar, Ansarin, Khalil, Mansournia, Mohammad Ali, Collins, Gary S., and Kaufman, Jay S.
- Subjects
WHEEZE ,GLOBAL burden of disease ,ASTHMA - Abstract
Background: Understanding global trends in the point prevalence, deaths, and disability-adjusted life-years (DALYs) for asthma will facilitate evidence-based decision-making.Research Question: What are the global, regional, and national burdens of asthma in 204 countries and territories between 1990 and 2019 by age, sex, and sociodemographic index (SDI)?Study Design and Methods: Publicly available data from the Global Burden of Disease study from 1990 through 2019 were used. All estimates were presented as counts and age-standardized rates per 100,000, along with their associated uncertainty intervals.Results: In 2019, the global age-standardized point prevalence and death rates for asthma were 3,415.5 and 5.8 per 100,000, which represent a 24% and 51.3% decrease since 1990, respectively. Moreover, in 2019, the global age-standardized DALY rate was 273.6 and the global point prevalence of asthma was highest in the group 5 to 9 years of age. Also in 2019, the United States (10,399.3) showed the highest age-standardized point prevalence rate of asthma. Generally, the burden of asthma decreased with increasing SDI. Globally, high BMI (16.9%), smoking (9.9%), and occupational asthmagens (8.8%) contributed to the 2019 asthma DALYs.Interpretation: Asthma remains an important public health issue, particularly in regions with low socioeconomic development. Future research is needed to examine thoroughly the associations asthma has with its risk factors and the factors impeding optimal self-management. Further research also is needed to understand and implement better the interventions that have reduced the burden of asthma. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
230. Burden of ischemic heart disease and its attributable risk factors in 204 countries and territories, 1990–2019.
- Author
-
Safiri, Saeid, Karamzad, Nahid, Singh, Kuljit, Carson-Chahhoud, Kristin, Adams, Cobi, Nejadghaderi, Seyed Aria, Almasi-Hashiani, Amir, Sullman, Mark J M, Mansournia, Mohammad Ali, Bragazzi, Nicola Luigi, Kaufman, Jay S, Collins, Gary S, and Kolahi, Ali-Asghar
- Published
- 2022
- Full Text
- View/download PDF
231. Neck pain: global epidemiology, trends and risk factors.
- Author
-
Kazeminasab, Somaye, Nejadghaderi, Seyed Aria, Amiri, Parastoo, Pourfathi, Hojjat, Araj-Khodaei, Mostafa, Sullman, Mark J. M., Kolahi, Ali-Asghar, and Safiri, Saeid
- Subjects
NECK pain ,EPIDEMIOLOGY ,MUSCULOSKELETAL system diseases ,HUMAN experimentation ,SEARCH engines ,PAIN management ,ANXIETY - Abstract
Background: Neck pain is one of the most common musculoskeletal disorders, having an age-standardised prevalence rate of 27.0 per 1000 population in 2019. This literature review describes the global epidemiology and trends associated with neck pain, before exploring the psychological and biological risk factors associated with the initiation and progression of neck pain.Methods: The PubMed database and Google Scholar search engine were searched up to May 21, 2021. Studies were included that used human subjects and evaluated the effects of biological or psychological factors on the occurrence or progression of neck pain, or reported its epidemiology.Results: Psychological risk factors, such as long-term stress, lack of social support, anxiety, and depression are important risk factors for neck pain. In terms of the biological risks, neck pain might occur as a consequence of certain diseases, such as neuromusculoskeletal disorders or autoimmune diseases. There is also evidence that demographic characteristics, such as age and sex, can influence the prevalence and development of neck pain, although further research is needed.Conclusions: The findings of the present study provide a comprehensive and informative overview that should be useful for the prevention, diagnosis, and management of neck pain. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
232. Epidemiology, prognosis and management of potassium disorders in Covid‐19.
- Author
-
Noori, Maryam, Nejadghaderi, Seyed A., Sullman, Mark J. M., Carson‐Chahhoud, Kristin, Kolahi, Ali‐Asghar, and Safiri, Saeid
- Abstract
Coronavirus disease (Covid‐19), caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), is currently the largest health crisis facing most countries. Several factors have been linked with a poor prognosis for this disease, including demographic factors, pre‐existing comorbidities and laboratory parameters such as white blood cell count, D‐dimer, C‐reactive protein, albumin, lactate dehydrogenase, creatinine and electrolytes. Electrolyte abnormalities particularly potassium disorders are common among Covid‐19 patients. Based on our pooled analysis, hypokalemia and hyperkalemia occur in 24.3% and 4.15% of Covid‐19 patients, respectively. Potassium level deviation from the normal range may increase the chances of unfavorable outcomes and even death. Therefore, this article reviewed the epidemiology of potassium disorders and explained how hypokalemia and hyperkalemia are capable of deteriorating cardiac outcomes and the prognosis of Covid‐19 for infected patients. The article finishes by highlighting some important considerations in the management of hypokalemia and hyperkalemia in these patients. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
233. Anger amongst New Zealand drivers
- Author
-
Sullman, Mark J.M.
- Published
- 2006
- Full Text
- View/download PDF
234. Spanish drivers and their aberrant driving behaviours
- Author
-
Eugenia Gras, M., Sullman, Mark J.M., Cunill, Monica, Planes, Montserrat, Aymerich, Maria, and Font-Mayolas, Silvia
- Published
- 2006
- Full Text
- View/download PDF
235. Perceived Acceptance of Condom Use by Partners, Close Friends, and Parents of Spanish and Mozambican Heterosexual Adolescents
- Author
-
Planes, Montserrat, Gras, Eugenia M., Cunill, Mónica, Cassamo, Hachimo, Sullman, Mark J. M., and Gómez, Ana B.
- Published
- 2012
- Full Text
- View/download PDF
236. The burden of kidney cancer and its attributable risk factors in 195 countries and territories, 1990–2017
- Author
-
Safiri, Saeid, primary, Kolahi, Ali-Asghar, additional, Mansournia, Mohammad Ali, additional, Almasi-Hashiani, Amir, additional, Ashrafi-Asgarabad, Ahad, additional, Sullman, Mark J. M., additional, Bettampadi, Deepti, additional, Qorbani, Mostafa, additional, Moradi-Lakeh, Maziar, additional, Ardalan, Mohammadreza, additional, Mokdad, Ali, additional, and Fitzmaurice, Christina, additional
- Published
- 2020
- Full Text
- View/download PDF
237. Psychometric properties of the Driving Behaviour Scale (DBS) among polish drivers
- Author
-
Przepiorka, Aneta M., primary, Hill, Tetiana, additional, Blachnio, Agata P., additional, Sullman, Mark J.M., additional, Taylor, Joanne E., additional, and Mamcarz, Piotr, additional
- Published
- 2020
- Full Text
- View/download PDF
238. Asthma and metabolic syndrome: a comprehensive systematic review and meta-analysis of observational studies
- Author
-
Karamzad, Nahid, primary, Izadi, Neda, additional, Sanaie, Sarvin, additional, Ahmadian, Elham, additional, Eftekhari, Aziz, additional, Sullman, Mark J.M., additional, and Safiri, Saeid, additional
- Published
- 2020
- Full Text
- View/download PDF
239. Cigarette, E-Cigarette and Waterpipe Use among Young Adults: Differential Cognitions about These Three Forms of Smoking
- Author
-
Sullman, Mark J.M., primary, Gras, Maria-Eugenia, additional, Kagialis, Antonios, additional, Papageorgi, Ioulia, additional, and Font-Mayolas, Sílvia, additional
- Published
- 2020
- Full Text
- View/download PDF
240. Measuring Anxiety-Related Avoidance With the Driving and Riding Avoidance Scale (DRAS)
- Author
-
Taylor, Joanne E., primary, Sullman, Mark J. M., additional, and Stephens, Amanda N., additional
- Published
- 2020
- Full Text
- View/download PDF
241. Sex and Polytobacco Use among Spanish and Turkish University Students
- Author
-
Font-Mayolas, Sílvia, primary, Sullman, Mark J. M., additional, and Gras, Maria-Eugenia, additional
- Published
- 2019
- Full Text
- View/download PDF
242. The global, regional, and national burden of colorectal cancer and its attributable risk factors in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
- Author
-
Safiri, Saeid, primary, Sepanlou, Sadaf G, additional, Ikuta, Kevin S, additional, Bisignano, Catherine, additional, Salimzadeh, Hamideh, additional, Delavari, Alireza, additional, Ansari, Reza, additional, Roshandel, Gholamreza, additional, Merat, Shahin, additional, Fitzmaurice, Christina, additional, Force, Lisa M, additional, Nixon, Molly R, additional, Abbastabar, Hedayat, additional, Abegaz, Kedir Hussein, additional, Afarideh, Mohsen, additional, Ahmadi, Ayat, additional, Ahmed, Muktar Beshir, additional, Akinyemiju, Tomi, additional, Alahdab, Fares, additional, Ali, Raghib, additional, Alikhani, Mahtab, additional, Alipour, Vahid, additional, Aljunid, Syed Mohamed, additional, Almadi, Majid Abdulrahman Hamad, additional, Almasi-Hashiani, Amir, additional, Al-Raddadi, Rajaa M, additional, Alvis-Guzman, Nelson, additional, Amini, Saeed, additional, Anber, Nahla Hamed, additional, Ansari-Moghaddam, Alireza, additional, Arabloo, Jalal, additional, Arefi, Zohreh, additional, Asghari Jafarabadi, Mohammad, additional, Azadmehr, Abbas, additional, Badawi, Alaa, additional, Baheiraei, Nafiseh, additional, Bärnighausen, Till Winfried, additional, Basaleem, Huda, additional, Behzadifar, Masoud, additional, Behzadifar, Meysam, additional, Belayneh, Yaschilal Muche, additional, Berhe, Kidanemaryam, additional, Bhattacharyya, Krittika, additional, Biadgo, Belete, additional, Bijani, Ali, additional, Biondi, Antonio, additional, Bjørge, Tone, additional, Borzì, Antonio M, additional, Bosetti, Cristina, additional, Bou-Orm, Ibrahim R., additional, Brenner, Hermann, additional, Briko, Andrey Nikolaevich, additional, Briko, Nikolay Ivanovich, additional, Carreras, Giulia, additional, Carvalho, Félix, additional, Castañeda-Orjuela, Carlos A, additional, Cerin, Ester, additional, Chiang, Peggy Pei-Chia, additional, Chido-Amajuoyi, Onyema Greg, additional, Daryani, Ahmad, additional, Davitoiu, Dragos Virgil, additional, Demoz, Gebre Teklemariam, additional, Desai, Rupak, additional, Dianati nasab, Mostafa, additional, Eftekhari, Aziz, additional, El Sayed, Iman, additional, Elbarazi, Iffat, additional, Emamian, Mohammad Hassan, additional, Endries, Aman Yesuf, additional, Esmaeilzadeh, Firooz, additional, Esteghamati, Alireza, additional, Etemadi, Arash, additional, Farzadfar, Farshad, additional, Fernandes, Eduarda, additional, Fernandes, João C, additional, Filip, Irina, additional, Fischer, Florian, additional, Foroutan, Masoud, additional, Gad, Mohamed M, additional, Gallus, Silvano, additional, Ghaseni-Kebria, Fatemeh, additional, Ghashghaee, Ahmad, additional, Gorini, Giuseppe, additional, Hafezi-Nejad, Nima, additional, Haj-Mirzaian, Arvin, additional, Haj-Mirzaian, Arya, additional, Hasanpour-Heidari, Susan, additional, Hasanzadeh, Amir, additional, Hassanipour, Soheil, additional, Hay, Simon I, additional, Hoang, Chi Linh, additional, Hostiuc, Mihaela, additional, Househ, Mowafa, additional, Ilesanmi, Olayinka Stephen, additional, Ilic, Milena D., additional, Innos, Kaire, additional, Irvani, Seyed Sina Naghibi, additional, Islami, Farhad, additional, Jaca, Anelisa, additional, Jafari Balalami, Nader, additional, Jafari delouei, Nastaran, additional, Jafarinia, Morteza, additional, Jahani, Mohammad Ali, additional, Jakovljevic, Mihajlo, additional, James, Spencer L., additional, Javanbakht, Mehdi, additional, Jenabi, Ensiyeh, additional, Jha, Ravi Prakash, additional, Joukar, Farahnaz, additional, Kasaeian, Amir, additional, Kassa, Tesfaye Dessale, additional, Kassaw, Mesfin Wudu, additional, Kengne, Andre Pascal, additional, Khader, Yousef Saleh, additional, Khaksarian, Mojtaba, additional, Khalilov, Rovshan, additional, Khan, Ejaz Ahmad, additional, Khayamzadeh, Maryam, additional, Khazaee-Pool, Maryam, additional, Khazaei, Salman, additional, Khosravi Shadmani, Fatemeh, additional, Khubchandani, Jagdish, additional, Kim, Daniel, additional, Kisa, Adnan, additional, Kisa, Sezer, additional, Kocarnik, Jonathan M, additional, Komaki, Hamidreza, additional, Kopec, Jacek A, additional, Koyanagi, Ai, additional, Kuipers, Ernst J., additional, Kumar, Vivek, additional, La Vecchia, Carlo, additional, Lami, Faris Hasan, additional, Lopez, Alan D, additional, Lopukhov, Platon D, additional, Lunevicius, Raimundas, additional, Majeed, Azeem, additional, Majidinia, Maryam, additional, Manafi, Amir, additional, Manafi, Navid, additional, Manda, Ana-Laura, additional, Mansour-Ghanaei, Fariborz, additional, Mantovani, Lorenzo Giovanni, additional, Mehta, Dhruv, additional, Meier, Toni, additional, Meles, Hagazi Gebre, additional, Mendoza, Walter, additional, Mestrovic, Tomislav, additional, Miazgowski, Bartosz, additional, Miazgowski, Tomasz, additional, Mir, Seyed Mostafa, additional, Mirzaei, Hamed, additional, Mohammad, Karzan Abdulmuhsin, additional, Mohammad Gholi Mezerji, Naser, additional, Mohammadian-Hafshejani, Abdollah, additional, Mohammadoo-Khorasani, Milad, additional, Mohammed, Shafiu, additional, Mohebi, Farnam, additional, Mokdad, Ali H, additional, Monasta, Lorenzo, additional, Moossavi, Maryam, additional, Moradi, Ghobad, additional, Moradpour, Farhad, additional, Moradzadeh, Rahmatollah, additional, Nahvijou, Azin, additional, Naik, Gurudatta, additional, Najafi, Farid, additional, Nazari, Javad, additional, Negoi, Ionut, additional, Nguyen, Cuong Tat, additional, Nguyen, Trang Huyen, additional, Ningrum, Dina Nur Anggraini, additional, Ogbo, Felix Akpojene, additional, Olagunju, Andrew T, additional, Olagunju, Tinuke O, additional, Pana, Adrian, additional, Pereira, David M., additional, Pirestani, Majid, additional, Pourshams, Akram, additional, Poustchi, Hossein, additional, Qorbani, Mostafa, additional, Rabiee, Mohammad, additional, Rabiee, Navid, additional, Radfar, Amir, additional, Rahmati, Marveh, additional, Rajati, Fatemeh, additional, Rawaf, David Laith, additional, Rawaf, Salman, additional, Reiner, Robert C, additional, Renzaho, Andre M N, additional, Rezaei, Nima, additional, Rezapour, Aziz, additional, Saad, Anas M, additional, Saadatagah, Seyedmohammad, additional, Saddik, Basema, additional, Salehi, Farkhonde, additional, Salehi Zahabi, Saleh, additional, Salz, Inbal, additional, Samy, Abdallah M, additional, Sanabria, Juan, additional, Santric Milicevic, Milena M, additional, Sarveazad, Arash, additional, Satpathy, Maheswar, additional, Schneider, Ione J C, additional, Sekerija, Mario, additional, Shaahmadi, Faramarz, additional, Shabaninejad, Hosein, additional, Shamsizadeh, Morteza, additional, Sharafi, Zeinab, additional, Sharif, Mehdi, additional, Sharifi, Amrollah, additional, Sheikhbahaei, Sara, additional, Shirkoohi, Reza, additional, Siddappa Malleshappa, Sudeep K, additional, Silva, Diego Augusto Santos, additional, Sisay, Mekonnen, additional, Smarandache, Catalin-Gabriel, additional, Soofi, Moslem, additional, Soreide, Kjetil, additional, Soshnikov, Sergey, additional, Starodubov, Vladimir I., additional, Subart, Michelle L., additional, Sullman, Mark JM, additional, Tabarés-Seisdedos, Rafael, additional, Taherkhani, Amir, additional, Tesfay, Berhe etsay, additional, Topor-Madry, Roman, additional, Traini, Eugenio, additional, Tran, Bach Xuan, additional, Tran, Khanh Bao, additional, Ullah, Irfan, additional, Uthman, Olalekan A, additional, Vacante, Marco, additional, Vahedian-Azimi, Amir, additional, Valli, Alessandro, additional, Varavikova, Elena, additional, Vujcic, Isidora S, additional, Westerman, Ronny, additional, Yazdi-Feyzabadi, Vahid, additional, Yisma, Engida, additional, Yu, Chuanhua, additional, Zadnik, Vesna, additional, Zahirian Moghadam, Telma, additional, Zaki, Leila, additional, Zandian, Hamed, additional, Zhang, Zhi-Jiang, additional, Murray, Christopher J L, additional, Naghavi, Mohsen, additional, and Malekzadeh, Reza, additional
- Published
- 2019
- Full Text
- View/download PDF
243. Dimensions of aberrant driving behaviour and their relation to crash involvement for drivers in New Zealand
- Author
-
Sullman, Mark J.M., primary, Stephens, Amanda N., additional, and Taylor, Joanne E., additional
- Published
- 2019
- Full Text
- View/download PDF
244. Developing the Driving Anger Scale
- Author
-
Sullman, Mark J.M., primary and Baas, Peter H., additional
- Published
- 2005
- Full Text
- View/download PDF
245. The effect of motorcycle safety campaign on helmet use: A systematic review and meta-analysis.
- Author
-
Akbari, Maryam, Lankarani, Kamran B., Tabrizi, Reza, Vali, Mohebat, Heydari, Seyed Taghi, Motevalian, Seyed Abbas, and Sullman, Mark J.M.
- Abstract
This systematic review and meta-analysis was undertaken to estimate the effectiveness of motorcycle safety campaigns for increasing helmet use among motorcycle riders and passengers. PubMed, Scopus, EMBASE, and the Web of Science (WOS) databases were systematically searched up June 2020 for all relevant studies. The National Institute of Health (NIH) tool was used to assess the quality of all included studies. Inter-study heterogeneity was measured using the Chi-Squared and I
2 statistics, with the odds ratio (OR) being used as a measure of the pooled effect size. Out of the 561 records identified from the literature searches, eight articles (or 11 studies) were eligible for inclusion in the present meta-analysis. Using a random effects model, the results of the meta-analysis demonstrated statistically significant increases in helmet use among motorcycle riders (OR = 4.52, 95% CI: 1.01–20.14, I2 = 99.9%) and passengers (OR = 6.57, 95% CI: 1.41–30.56, I2 = 99.9%). The findings of sensitivity analyses, based on alternative levels of r for imputing the standard error (SE) of the ORs, showed the pooled OR of helmet use among motorcycle riders (r = 0.7; 3.49; 95% CI: 0.78, 16.44; r = 0.9; 3.49; 95% CI: 0.76, 16.11) was sensitive to different levels of r. However, no significant effect was detected on the pooled effect size for different correlation coefficients for motorcycle passengers (r = 0.7; 6.56; 95% CI: 1.59, 27.00; r = 0.9; 6.56; 95% CI: 2.25, 19.13). Increases in helmet use among motorcycle passengers were found in studies that: monitored pre and post campaign periods for longer than one year and were conducted in Thailand or Vietnam. However, the effect of motorcycle safety campaigns on helmet use among motorcycle riders remained significant for all of the different strata included. The present meta-analysis found that motorcycle safety campaigns can lead to a significant increase in helmet use among both motorcycle riders and passengers. Due to the high degree of inter study heterogeneity, these findings should be interpreted with some caution. Despite the apparent favourable influence of motorcycle safety campaigns, more robust research is required. • The meta-analysis demonstrated statistically significant increases in helmet use among motorcycle riders and passengers. • Increases in helmet use among motorcycle passengers were found in studies that: monitored pre and post campaign periods for longer than one year and were conducted in Thailand or Vietnam. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
246. Global, regional, and national burden of Guillain-Barré syndrome and its underlying causes from 1990 to 2019.
- Author
-
Bragazzi, Nicola Luigi, Kolahi, Ali-Asghar, Nejadghaderi, Seyed Aria, Lochner, Piergiorgio, Brigo, Francesco, Naldi, Andrea, Lanteri, Paola, Garbarino, Sergio, Sullman, Mark J. M., Dai, Haijiang, Wu, Jianhong, Kong, Jude Dzevela, Jahrami, Haitham, Sohrabi, Mohammad-Reza, and Safiri, Saeid
- Subjects
GUILLAIN-Barre syndrome ,RESPIRATORY infections ,GLOBAL burden of disease ,URINARY incontinence ,DISABILITIES ,COMMUNICABLE diseases - Abstract
Background: This article presents the first detailed analysis of the prevalence and disability burden of Guillain-Barré syndrome (GBS) from 1990 to 2019 by cause, age, sex, and Socio-demographic Index (SDI) in 204 countries and territories.Methods: Data from the Global Burden of Diseases Study (GBD) 2019 were used. GBD 2019 modelled the prevalence of GBS using hospital and claims data. Years lived with disability (YLDs) were estimated as the product of the GBS prevalence and the disability weight. This article also reported proportions in the age-standardised prevalence rate that were due to six underlying causes of GBS.Results: In 2019, there were 150,095 [95% uncertainty intervals (UI) 119,924 to 188,309] total cases of GBS worldwide, which resulted in 44,407 (95% UI 28,016 to 64,777) YLDs. Globally, there was a 6.4% (95% UI 3.6 to 9.5) increase in the age-standardised prevalence of GBS per 100,000 population between 1990 and 2019. High-income Asia Pacific [1.9 (95% UI: 1.5 to 2.4)] and East Asia [0.8 (95% UI: 0.6 to 1.0)] had the highest and lowest age-standardised prevalence rates (per 100,000), respectively, in 2019. Nationally, Japan [6.4 (95% UI: 5.3 to 7.7)] and China [0.8 (95% UI: 0.6 to 1.0)] had the highest and lowest age-standardised prevalence rates (per 100,000). The age-standardised burden of GBS increased with increasing age and was higher in males in all age groups. Furthermore, the age-standardised prevalence of GBS (per 100,000) had a positive association with the level of development, as measured by SDI, although this association was not strong. Upper respiratory infections and unknown causes accounted for the highest proportions of underlying causes.Conclusions: Globally, the prevalence of GBS continues to increase. Geographical differences and strategies aimed at preventing infectious diseases should be considered in future health policy planning and decision-making processes. This study had several limitations, such as using the same disability weight for all causes and a reliance on hospital- and self-reported data, which should be addressed in future research. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
247. Burden of anemia and its underlying causes in 204 countries and territories, 1990–2019: results from the Global Burden of Disease Study 2019.
- Author
-
Safiri, Saeid, Kolahi, Ali-Asghar, Noori, Maryam, Nejadghaderi, Seyed Aria, Karamzad, Nahid, Bragazzi, Nicola Luigi, Sullman, Mark J. M., Abdollahi, Morteza, Collins, Gary S., Kaufman, Jay S., and Grieger, Jessica A.
- Subjects
GLOBAL burden of disease ,DEVELOPING countries ,ANEMIA ,HEMOLYTIC anemia ,IRON supplements ,URINARY incontinence - Abstract
Background: Anemia is a common disease which affects around 40% of children and 30% of reproductive age women and can have major health consequences. The present study reports the global, regional and national burden of anemia and its underlying causes between 1990 and 2019, by age, sex and socio-demographic index (SDI). Methods: Publicly available data on the point prevalence and years lived with disability (YLDs) were retrieved from the global burden of disease (GBD) 2019 study for 204 countries and territories between 1990 and 2019. The point prevalence, YLD counts and rates per 100,000 population were presented, along with their corresponding 95% uncertainty intervals. Results: In 2019, the global age-standardized point prevalence and YLD rates for anemia were 23,176.2 (22,943.5–23,418.6) and 672.4 (447.2–981.5) per 100,000 population, respectively. Moreover, the global age-standardized point prevalence and YLD rate decreased by 13.4% (12.1–14.5%) and 18.8% (16.9–20.8%), respectively, over the period 1990–2019. The highest national point prevalences of anemia were found in Zambia [49327.1 (95% UI: 46,838.5–51,700.1)], Mali [46890.1 (95% UI: 44,301.1–49,389.8)], and Burkina Faso [46117.2 (95% UI: 43,640.7–48,319.2)]. In 2019, the global point prevalence of anemia was highest in the 15–19 and 95+ age groups in females and males, respectively. Also, the burden of anemia was lower in regions with higher socio-economic development. Globally, most of the prevalent cases were attributable to dietary iron deficiency, as well as hemoglobinopathies and hemolytic anemias. Conclusions: Anemia remains a major health problem, especially among females in less developed countries. The implementation of preventive programs with a focus on improving access to iron supplements, early diagnosis and the treatment of hemoglobinopathies should be taken into consideration. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
248. Errors, Lapses and Violations in the Drivers of Heavy Vehicles
- Author
-
Sullman, Mark J.M., primary, Meadows, Michelle, additional, and Pajo, Karl, additional
- Published
- 2004
- Full Text
- View/download PDF
249. The global, regional, and national burden of colorectal cancer and its attributable risk factors in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
- Author
-
Safiri, Saeid, Sepanlou, Sadaf G., Ikuta, Kevin S., Bisignano, Catherine, Salimzadeh, Hamideh, Delavari, Alireza, Ansari, Reza, Roshandel, Gholamreza, Merat, Shahin, Fitzmaurice, Christina, Force, Lisa M., Nixon, Molly R., Abbastabar, Hedayat, Abegaz, Kedir Hussein, Afarideh, Mohsen, Ahmadi, Ayat, Ahmed, Muktar Beshir, Akinyemiju, Tomi, Alahdab, Fares, Ali, Raghib, Alikhani, Mahtab, Alipour, Vahid, Aljunid, Syed Mohamed, Almadi, Majid Abdulrahman Hamad, Almasi-Hashiani, Amir, Al-Raddadi, Rajaa M., Alvis-Guzman, Nelson, Amini, Saeed, Anber, Nahla Hamed, Ansari-Moghaddam, Alireza, Arabloo, Jalal, Arefi, Zohreh, Jafarabadi, Mohammad Asghari, Azadmehr, Abbas, Badawi, Alaa, Baheiraei, Nafiseh, Barnighausen, Till Winfried, Basaleem, Huda, Behzadifar, Masoud, Behzadifar, Meysam, Belayneh, Yaschilal Muche, Berhe, Kidanemaryam, Bhattacharyya, Krittika, Biadgo, Belete, Bijani, Ali, Biondi, Antonio, Bjorge, Tone, Borzi, Antonio M., Bosetti, Cristina, Bou-Orm, Ibrahim R., Brenner, Hermann, Briko, Andrey Nikolaevich, Briko, Nikolay Ivanovich, Carreras, Giulia, Carvalho, Felix, Castaneda-Orjuela, Carlos A., Cerin, Ester, Chiang, Peggy Pei-Chia, Chido-Amajuoyi, Onyema Greg, Daryani, Ahmad, Davitoiu, Dragos Virgil, Demoz, Gebre Teklemariam, Desai, Rupak, Nasab, Mostafa Dianati, Eftekhari, Aziz, El Sayed, Iman, Elbarazi, Iffat, Emamian, Mohammad Hassan, Endries, Aman Yesuf, Esmaeilzadeh, Firooz, Esteghamati, Alireza, Etemadi, Arash, Farzadfar, Farshad, Fernandes, Eduarda, Fernandes, Joao C., Filip, Irina, Fischer, Florian, Foroutan, Masoud, Gad, Mohamed M., Gallus, Silvano, Ghaseni-Kebria, Fatemeh, Ghashghaee, Ahmad, Gorini, Giuseppe, Hafezi-Nejad, Nima, Haj-Mirzaian, Arvin, Haj-Mirzaian, Arya, Hasanpour-Heidari, Susan, Hasanzadeh, Amir, Hassanipour, Soheil, Hay, Simon, I, Hoang, Chi Linh, Hostiuc, Mihaela, Househ, Mowafa, Ilesanmi, Olayinka Stephen, Ilic, Milena D., Innos, Kaire, Irvani, Seyed Sina Naghibi, Islami, Farhad, Jaca, Anelisa, Balalami, Nader Jafari, Delouei, Nastaran Jafari, Jafarinia, Morteza, Jahani, Mohammad Ali, Jakovljevic, Mihajlo, James, Spencer L., Javanbakht, Mehdi, Jenabi, Ensiyeh, Jha, Ravi Prakash, Joukar, Farahnaz, Kasaeian, Amir, Kassa, Tesfaye Dessale, Kassaw, Mesfin Wudu, Kengne, Andre Pascal, Khader, Yousef Saleh, Khaksarian, Mojtaba, Khalilov, Rovshan, Khan, Ejaz Ahmad, Khayamzadeh, Maryam, Khazaee-Pool, Maryam, Khazaei, Salman, Shadmani, Fatemeh Khosravi, Khubchandani, Jagdish, Kim, Daniel, Kisa, Adnan, Kisa, Sezer, Kocarnik, Jonathan M., Komaki, Hamidreza, Kopec, Jacek A., Koyanagi, Ai, Kuipers, Ernst J., Kumar, Vivek, La Vecchia, Carlo, Lami, Faris Hasan, Lopez, Alan D., Lopukhov, Platon D., Lunevicius, Raimundas, Majeed, Azeem, Majidinia, Maryam, Manafi, Amir, Manafi, Navid, Manda, Ana-Laura, Mansour-Ghanaei, Fariborz, Mantovani, Lorenzo Giovanni, Mehta, Dhruv, Meier, Toni, Meles, Hagazi Gebre, Mendoza, Walter, Mestrovic, Tomislav, Miazgowski, Bartosz, Miazgowski, Tomasz, Mir, Seyed Mostafa, Mirzaei, Hamed, Mohammad, Karzan Abdulmuhsin, Mezerji, Naser Mohammad Gholi, Mohammadian-Hafshejani, Abdollah, Mohammadoo-Khorasani, Milad, Mohammed, Shafiu, Mohebi, Farnam, Mokdad, Ali H., Monasta, Lorenzo, Moossavi, Maryam, Moradi, Ghobad, Moradpour, Farhad, Moradzadeh, Rahmatollah, Nahvijou, Azin, Naik, Gurudatta, Najafi, Farid, Nazari, Javad, Negoi, Ionut, Negru, Serban, Cuong Tat Nguyen, Cuong Tat Nguyen, Trang Huyen Nguyen, Trang Huyen Nguyen, Ningrum, Dina Nur Anggraini, Ogbo, Felix Akpojene, Olagunju, Andrew T., Olagunju, Tinuke O., Pana, Adrian, Pereira, David M., Pirestani, Majid, Pourshams, Akram, Poustchi, Hossein, Qorbani, Mostafa, Rabiee, Mohammad, Rabiee, Navid, Radfar, Amir, Rahmati, Marveh, Rajati, Fatemeh, Raoofi, Samira, Rawaf, David Laith, Rawaf, Salman, Reiner, Robert C., Jr., Renzaho, Andre M. N., Rezaei, Nima, Rezapour, Aziz, Saad, Anas M., Saadatagah, Seyedmohammad, Saddik, Basema, Salehi, Farkhonde, Zahabi, Saleh Salehi, Salz, Inbal, Samy, Abdallah M., Sanabria, Juan, Milicevic, Milena M. Santric, Sarveazad, Arash, Satpathy, Maheswar, Schneider, Ione J. C., Sekerija, Mario, Shaahmadi, Faramarz, Shabaninejad, Hosein, Shamsizadeh, Morteza, Sharafi, Zeinab, Sharif, Mehdi, Sharifi, Amrollah, Sheikhbahaei, Sara, Shirkoohi, Reza, Malleshappa, Sudeep K. Siddappa, Silva, Diego Augusto Santos, Sisay, Mekonnen, Smarandache, Catalin-Gabriel, Soofi, Moslem, Soreide, Kjetil, Soshnikov, Sergey, Starodubov, Vladimir, I, Tabares-Seisdedos, Rafael, Sullman, Mark, Taherkhani, Amir, Tesfay, Berhe Etsay, Topor-Madry, Roman, Traini, Eugenio, Bach Xuan Tran, Bach Xuan Tran, Khanh Bao Tran, Khanh Bao Tran, Ullah, Irfan, Uthman, Olalekan A., Vacante, Marco, Vahedian-Azimi, Amir, Valli, Alessandro, Varavikova, Elena, Vujcic, Isidora S., Westerman, Ronny, Yazdi-Feyzabadi, Vahid, Yisma, Engida, Yu, Chuanhua, Zadnik, Vesna, Moghadam, Telma Zahirian, Zaki, Leila, Zandian, Hamed, Zhang, Zhi-Jiang, Murray, Christopher J. L., Naghavi, Mohsen, Malekzadeh, Reza, Veritati - Repositório Institucional da Universidade Católica Portuguesa, Safiri, S, Sepanlou, S, Ikuta, K, Bisignano, C, Salimzadeh, H, Delavari, A, Ansari, R, Roshandel, G, Merat, S, Fitzmaurice, C, Force, L, Nixon, M, Abbastabar, H, Abegaz, K, Afarideh, M, Ahmadi, A, Ahmed, M, Akinyemiju, T, Alahdab, F, Ali, R, Alikhani, M, Alipour, V, Aljunid, S, Almadi, M, Almasi-Hashiani, A, Al-Raddadi, R, Alvis-Guzman, N, Amini, S, Anber, N, Ansari-Moghaddam, A, Arabloo, J, Arefi, Z, Asghari Jafarabadi, M, Azadmehr, A, Badawi, A, Baheiraei, N, Barnighausen, T, Basaleem, H, Behzadifar, M, Belayneh, Y, Berhe, K, Bhattacharyya, K, Biadgo, B, Bijani, A, Biondi, A, Bjorge, T, Borzi, A, Bosetti, C, Bou-Orm, I, Brenner, H, Briko, A, Briko, N, Carreras, G, Carvalho, F, Castaneda-Orjuela, C, Cerin, E, Chiang, P, Chido-Amajuoyi, O, Daryani, A, Davitoiu, D, Demoz, G, Desai, R, Dianati Nasab, M, Eftekhari, A, El Sayed, I, Elbarazi, I, Emamian, M, Endries, A, Esmaeilzadeh, F, Esteghamati, A, Etemadi, A, Farzadfar, F, Fernandes, E, Fernandes, J, Filip, I, Fischer, F, Foroutan, M, Gad, M, Gallus, S, Ghaseni-Kebria, F, Ghashghaee, A, Gorini, G, Hafezi-Nejad, N, Haj-Mirzaian, A, Hasanpour-Heidari, S, Hasanzadeh, A, Hassanipour, S, Hay, S, Hoang, C, Hostiuc, M, Househ, M, Ilesanmi, O, Ilic, M, Innos, K, Irvani, S, Islami, F, Jaca, A, Jafari Balalami, N, Jafari Delouei, N, Jafarinia, M, Jahani, M, Jakovljevic, M, James, S, Javanbakht, M, Jenabi, E, Jha, R, Joukar, F, Kasaeian, A, Kassa, T, Kassaw, M, Kengne, A, Khader, Y, Khaksarian, M, Khalilov, R, Khan, E, Khayamzadeh, M, Khazaee-Pool, M, Khazaei, S, Khosravi Shadmani, F, Khubchandani, J, Kim, D, Kisa, A, Kisa, S, Kocarnik, J, Komaki, H, Kopec, J, Koyanagi, A, Kuipers, E, Kumar, V, La Vecchia, C, Lami, F, Lopez, A, Lopukhov, P, Lunevicius, R, Majeed, A, Majidinia, M, Manafi, A, Manafi, N, Manda, A, Mansour-Ghanaei, F, Mantovani, L, Mehta, D, Meier, T, Meles, H, Mendoza, W, Mestrovic, T, Miazgowski, B, Miazgowski, T, Mir, S, Mirzaei, H, Mohammad, K, Mohammad Gholi Mezerji, N, Mohammadian-Hafshejani, A, Mohammadoo-Khorasani, M, Mohammed, S, Mohebi, F, Mokdad, A, Monasta, L, Moossavi, M, Moradi, G, Moradpour, F, Moradzadeh, R, Nahvijou, A, Naik, G, Najafi, F, Nazari, J, Negoi, I, Negru, S, Nguyen, C, Nguyen, T, Ningrum, D, Ogbo, F, Olagunju, A, Olagunju, T, Pana, A, Pereira, D, Pirestani, M, Pourshams, A, Poustchi, H, Qorbani, M, Rabiee, M, Rabiee, N, Radfar, A, Rahmati, M, Rajati, F, Raoofi, S, Rawaf, D, Rawaf, S, Reiner, R, Renzaho, A, Rezaei, N, Rezapour, A, Saad, A, Saadatagah, S, Saddik, B, Salehi, F, Zahabi, S, Salz, I, Samy, A, Sanabria, J, Santric Milicevic, M, Sarveazad, A, Satpathy, M, Schneider, I, Sekerija, M, Shaahmadi, F, Shabaninejad, H, Shamsizadeh, M, Sharafi, Z, Sharif, M, Sharifi, A, Sheikhbahaei, S, Shirkoohi, R, Siddappa Malleshappa, S, Silva, D, Sisay, M, Smarandache, C, Soofi, M, Soreide, K, Soshnikov, S, Starodubov, V, Tabares-Seisdedos, R, Sullman, M, Taherkhani, A, Tesfay, B, Topor-Madry, R, Traini, E, Tran, B, Tran, K, Ullah, I, Uthman, O, Vacante, M, Vahedian-Azimi, A, Valli, A, Varavikova, E, Vujcic, I, Westerman, R, Yazdi-Feyzabadi, V, Yisma, E, Yu, C, Zadnik, V, Zahirian Moghadam, T, Zaki, L, Zandian, H, Zhang, Z, Murray, C, Naghavi, M, Malekzadeh, R, Safiri, Saeid, Sepanlou, Sadaf G, Ikuta, Kevin S, Bisignano, C., Yisma, Engida, Malekzadeh, Reza, GBD 2017 Colorectal Cancer Collaborators, and Gastroenterology & Hepatology
- Subjects
Hepatology ,Gastroenterology ,global health ,colorectal neoplasms ,Global Health ,Corrections ,Article ,Global Burden of Disease ,SDG 3 - Good Health and Well-being ,Risk Factors ,Humans ,global disease burden ,Colorectal Neoplasms ,GBD 2017 Colorectal Cancer Collaborators ,medicine (all) ,colorectal tumor - Abstract
Background Data about the global, regional, and country-specific variations in the levels and trends of colorectal cancer are required to understand the impact of this disease and the trends in its burden to help policy makers allocate resources. Here we provide a status report on the incidence, mortality, and disability caused by colorectal cancer in 195 countries and territories between 1990 and 2017. Methods Vital registration, sample vital registration, verbal autopsy, and cancer registry data were used to generate incidence, death, and disability-adjusted life-year (DALY) estimates of colorectal cancer at the global, regional, and national levels. We also determined the association between development levels and colorectal cancer age-standardised DALY rates, and calculated DALYs attributable to risk factors that had evidence of causation with colorectal cancer. All of the estimates are reported as counts and age-standardised rates per 100 000 person-years, with some estimates also presented by sex and 5-year age groups. Findings In 2017, there were 1.8 million (95% UI 1.8-1.9) incident cases of colorectal cancer globally, with an age-standardised incidence rate of 23.2 (22.7-23.7) per 100 000 person-years that increased by 9.5% (4.5-13.5) between 1990 and 2017. Globally, colorectal cancer accounted for 896 000 (876 300-915 700) deaths in 2017, with an age-standardised death rate of 11.5 (11.3-11.8) per 100 000 person-years, which decreased between 1990 and 2017 (-13.5% [-18.4 to -10.0]). Colorectal cancer was also responsible for 19.0 million (18.5-19.5) DALYs globally in 2017, with an age-standardised rate of 235.7 (229.7-242.0) DALYs per 100 000 person-years, which decreased between 1990 and 2017 (-14.5% [-20.4 to -10.3]). Slovakia, the Netherlands, and New Zealand had the highest age-standardised incidence rates in 2017. Greenland, Hungary, and Slovakia had the highest age-standardised death rates in 2017. Numbers of incident cases and deaths were higher among males than females up to the ages of 80-84 years, with the highest rates observed in the oldest age group (>= 95 years) for both sexes in 2017. There was a non-linear association between the Socio-demographic Index and the Healthcare Access and Quality Index and age-standardised DALY rates. In 2017, the three largest contributors to DALYs at the global level, for both sexes, were diet low in calcium (20.5% [12.9-28.9]), alcohol use (15.2% [12.1-18.3]), and diet low in milk (14.3% [5.1-24.8]). Interpretation There is substantial global variation in the burden of colorectal cancer. Although the overall colorectal cancer age-standardised death rate has been decreasing at the global level, the increasing age-standardised incidence rate in most countries poses a major public health challenge across the world. The results of this study could be useful for policy makers to carry out cost-effective interventions and to reduce exposure to modifiable risk factors, particularly in countries with high incidence or increasing burden. Copyright (C) 2019 The Author(s). Published by Elsevier Ltd.
- Published
- 2019
250. The Connor-Davidson resilience scale (CD-RISC) amongst young Spanish adults
- Author
-
Gras, Maria-Eugenia, Font-Mayolas, Sílvia, Baltasar, Alícia, Patiño, Josefina, Sullman, Mark J. M., and Planes, Montserrat
- Subjects
Connor-Davidson Resilience Scale (CD-RISC) ,Adultos jóvenes españoles ,Resilience ,Young Spanish adults ,Resiliencia ,Escala de Resiliencia de Connor-Davidson (CD-RISC) - Abstract
The interest in resilience has grown over the last few decades due to its relationships with health, well-being, and quality of life. Several instruments have been developed to measure resilience, with one of the most common being the Connor-Davidson Resilience Scale (CD-RISC). This scale has been validated in many cultures with divergent results. This paper investigates the factor structure of the CD-RISC. Participants were 3,214 students (62.1% female, mean age = 21.01, SD = 2.86) who were randomly divided into two equal subsamples (n = 1,607). One subsample was used to explore which models best fit the data and these models were fitted using the other subsample. Confirmatory factor analysis did not support the original 5-factor CD-RISC. The analyses supported unidimensional scale structures for both the 22-item and 10-item versions of the scale. The shorter instrument reduces the time needed to answer the questionnaire, allows it to be combined with other instruments, and does not require large sample sizes. RESUMEN El interés por el estudio de la resiliencia ha aumentado en las últimas décadas debido a su relación con la salud, el bienestar y la calidad de vida. Se han desarrollado diversos instrumentos para medir la resiliencia, siendo uno de los más comunes la Escala de Resiliencia de Connor-Davidson (CD-RISC). Esta escala ha sido validada en muchas culturas con resultados diversos. En este trabajo se analiza la estructura factorial del CD-RISC en una muestra de 3,214 estudiantes (62.1% mujeres, edad media =21.01, DT = 2.86) que fueron divididos aleatoriamente en dos submuestras iguales (n = 1,607). Se exploró en una de las submuestras qué modelos se ajustaban mejor a los datos y estos modelos fueron ajustados en la otra submuestra. El análisis factorial confirmatorio no avaló la estructura de 5 factores del CD-RISC, sino que confirmó una estructura unidimensional de 22 y de 10 items. La escala de 10 items reduce el tiempo de aplicación del cuestionario, permite combinarlo con otros instrumentos y no requiere muestras muy grandes.
- Published
- 2019
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.